Managers / Q3 2020 · view latest →
ACME, LLC
CIK 0001803200 · 350 MISSION STREET, FLOOR 25, SAN FRANCISCO, CA, 94105 · 415-805-8500
Summary
Acme, LLC reported $336M in U.S.-listed holdings across 3 positions for Q3 2020.
The portfolio is heavily concentrated: DKNG1USD alone accounts for 94.1% of reported value.
The book was largely unchanged from Q2 2020.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 99.9% · $335M
- Other · 0.1% · $415,000
Quarter-over-Quarter Changes full breakdown →
vs Q2 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| DKNG1USDDRAFTKINGS INC | TRIMMED | −946.7K | 5.36M | +$106M | $316M |
| UBERUBER TECHNOLOGIES INC | HELD | +0 | 535.2K | +$3M | $20M |
| 1LIFE HEALTHCARE INC | HELD | +0 | 14.6K | −$117,000 | $415,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2020
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | DKNG1USDDRAFTKINGS INChistory → | COM CL A | 94.06% | $316M | 5.36M |
| 2 | UBERUBER TECHNOLOGIES INChistory → | COM | 5.82% | $20M | 535.2K |
| 3 | 1LIFE HEALTHCARE INC | COM | 0.12% | $415,000 | 14.6K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $8M | 3 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $10M | 3 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $18M | 3 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $19M | 4 | Aug 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $19M | 4 | May 15, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $33M | 5 | Feb 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $41M | 5 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $42M | 6 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $58M | 7 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $64M | 7 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $77M | 7 | Nov 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $80M | 8 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $108M | 8 | May 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $98M | 9 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $112M | 9 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $134M | 9 | Aug 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $306M | 9 | May 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $542M | 8 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $566M | 8 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $55M | 4 | Jul 29, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $68M | 3 | May 11, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $272M | 3 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $336M | 3 | Nov 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $227M | 3 | Jul 27, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $15M | 1 | Apr 24, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $53M | 1 | Feb 13, 2020 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.